141 related articles for article (PubMed ID: 35419208)
1. The Prognostic Potential of Neurokinin 1 Receptor in Breast Cancer and Its Relationship with Ki-67 Index.
Al-Keilani MS; Elstaty R; Alqudah MA
Int J Breast Cancer; 2022; 2022():4987912. PubMed ID: 35419208
[TBL] [Abstract][Full Text] [Related]
2. Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival.
Al-Keilani MS; Bdeir R; Elstaty RI; Alqudah MA
BMC Cancer; 2023 Feb; 23(1):158. PubMed ID: 36797689
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer.
Aleskandarany MA; Green AR; Benhasouna AA; Barros FF; Neal K; Reis-Filho JS; Ellis IO; Rakha EA
Breast Cancer Res; 2012 Jan; 14(1):R3. PubMed ID: 22225836
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of substance P in breast cancer and its association with prognostic parameters and Ki-67 index.
Al-Keilani MS; Elstaty RI; Alqudah MA; Alkhateeb AM
PLoS One; 2021; 16(6):e0252616. PubMed ID: 34086748
[TBL] [Abstract][Full Text] [Related]
6. Difference between Luminal A and Luminal B Subtypes According to Ki-67, Tumor Size, and Progesterone Receptor Negativity Providing Prognostic Information.
Inic Z; Zegarac M; Inic M; Markovic I; Kozomara Z; Djurisic I; Inic I; Pupic G; Jancic S
Clin Med Insights Oncol; 2014; 8():107-11. PubMed ID: 25249766
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of Ki-67 proliferating index in triple negative breast carcinomas.
Mrklić I; Ćapkun V; Pogorelić Z; Tomić S
Pathol Res Pract; 2013 May; 209(5):296-301. PubMed ID: 23601837
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor receptor 1 protein (FGFR1) as potential prognostic and predictive marker in patients with luminal B breast cancers overexpressing human epidermal receptor 2 protein (HER2).
Amina B; Lynda AK; Sonia S; Adel B; Jelloul BH; Miloud M; Tewfik S
Indian J Pathol Microbiol; 2021; 64(2):254-260. PubMed ID: 33851617
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of Ki-67 antigen expression between luminal A and triple-negative subtypes of breast cancer.
Borges US; Costa-Silva DR; da Silva-Sampaio JP; Escórcio-Dourado CS; Conde AM; Campelo V; Gebrim LH; da Silva BB; Lopes-Costa PV
Med Oncol; 2017 Sep; 34(9):156. PubMed ID: 28780646
[TBL] [Abstract][Full Text] [Related]
10. Calretinin expression as a reliable prognostic marker in different molecular subtypes of breast carcinoma.
Farrag MS; El-Karef AA; Amin MM; Helal NM; Ali OF; Farrag NS
Indian J Pathol Microbiol; 2017; 60(1):8-14. PubMed ID: 28195084
[TBL] [Abstract][Full Text] [Related]
11. Cinical Significance of Androgen Receptor, CK-5/6, KI-67 and Molecular Subtypes in Breast Cancer.
Kayahan M; İdiz UO; Gucin Z; Erözgen F; Memmi N; Müslümanoğlu M
J Breast Health; 2014 Oct; 10(4):201-208. PubMed ID: 28331672
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast.
Jin H; Ji M; Chen L; Liu Q; Che S; Xu M; Lin Z
J Exp Clin Cancer Res; 2016 Mar; 35():42. PubMed ID: 26955804
[TBL] [Abstract][Full Text] [Related]
13. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.
Belev B; Brčić I; Prejac J; Golubić ZA; Vrbanec D; Božikov J; Alerić I; Boban M; Razumović JJ
World J Gastroenterol; 2013 Jan; 19(4):523-7. PubMed ID: 23382631
[TBL] [Abstract][Full Text] [Related]
14. TGFβ regulates NK1R-Tr to affect the proliferation and apoptosis of breast cancer cells.
Wang L; Wang N; Zhang R; Dong D; Liu R; Zhang L; Ji W; Yu M; Zhang F; Niu R; Zhou Y
Life Sci; 2020 Sep; 256():117674. PubMed ID: 32380077
[TBL] [Abstract][Full Text] [Related]
15. MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis.
Zhang L; Wang L; Dong D; Wang Z; Ji W; Yu M; Zhang F; Niu R; Zhou Y
Cell Prolif; 2019 Jan; 52(1):e12527. PubMed ID: 30334298
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in breast cancer.
Davoodian M; Boroumand N; Mehrabi Bahar M; Jafarian AH; Asadi M; Hashemy SI
Mol Biol Rep; 2019 Feb; 46(1):1285-1293. PubMed ID: 30684188
[TBL] [Abstract][Full Text] [Related]
17. Ki-67 as a prognostic marker according to breast cancer molecular subtype.
Soliman NA; Yussif SM
Cancer Biol Med; 2016 Dec; 13(4):496-504. PubMed ID: 28154782
[TBL] [Abstract][Full Text] [Related]
18. MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers.
Sadeghian D; Saffar H; Mahdavi Sharif P; Soleimani V; Jahanbin B
Diagn Pathol; 2022 Feb; 17(1):24. PubMed ID: 35125121
[TBL] [Abstract][Full Text] [Related]
19. New developments in breast cancer prognosis: molecular predictors of treatment response and survival.
Foo EM; Boost MV; Wong AS; Loo WT; Chow LW; Chow CY
Int J Biol Markers; 2013 Jun; 28(2):131-40. PubMed ID: 23709349
[TBL] [Abstract][Full Text] [Related]
20. TIMAP Upregulation Correlates Negatively with Survival in HER2- Negative Subtypes of Breast Cancer.
Obeidat M; Bodoor K; Alqudah M; Masaadeh A; Barukba M; Almomani R
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1899-1905. PubMed ID: 34181349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
